| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Revenue | $540.5M | +21.3% |
| Cost of Revenue | $367.0M | +20.5% |
| Gross Profit | $173.5M | +22.9% |
| R&D Expense | $64.3M | +17.5% |
| SG&A Expense | $131.9M | +36.8% |
| Operating Income | -$178.7M | -1707.0% |
| Pre-tax Income | -$190.8M | -1339.8% |
| Income Tax | -$14.7M | -41.4% |
| Net Income | -$176.2M |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $132.9M | +72.0% |
| Short-term Investments | $24.7M | +0.0% |
| Accounts Receivable | $87.6M | +45.6% |
| Inventory | $138.8M | +53.2% |
| Current Assets | $477.0M | +29.3% |
| Total Assets | $824.6M | -9.8% |
| Current Liabilities | $121.3M | +19.7% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.4M | +218.5% |
| Capital Expenditures | $14.9M | -33.3% |
| Investing Cash Flow | -$7.0M | +86.6% |
| Financing Cash Flow | $50.8M | +406.1% |
| Free Cash Flow | -$3.5M | +89.1% |
| -4109.5% |
| EPS (Basic) | -$7.04 | -4041.2% |
| EPS (Diluted) | -$7.04 | -4041.2% |
| Long-term Debt |
| $135.0M |
| -28.9% |
| Stockholders' Equity | $551.0M | -9.4% |